Nanjing Julong Science & TechnologyLTD Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Nanjing Julong Science & TechnologyLTD.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Chemicals earnings growth | 39.6% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Nanjing Julong Science & Technology Co.,LTD's (SZSE:300644) 39% Share Price Surge Not Quite Adding Up
Oct 08
Nanjing Julong Science & TechnologyLTD (SZSE:300644) Is Looking To Continue Growing Its Returns On Capital
Sep 30Little Excitement Around Nanjing Julong Science & Technology Co.,LTD's (SZSE:300644) Earnings As Shares Take 26% Pounding
Jul 19Nanjing Julong Science & TechnologyLTD (SZSE:300644) Is Paying Out A Larger Dividend Than Last Year
Jul 05There's Reason For Concern Over Nanjing Julong Science & Technology Co.,LTD's (SZSE:300644) Massive 35% Price Jump
Apr 25There's Been No Shortage Of Growth Recently For Nanjing Julong Science & TechnologyLTD's (SZSE:300644) Returns On Capital
Apr 02Nanjing Julong Science & Technology Co.,LTD (SZSE:300644) Held Back By Insufficient Growth Even After Shares Climb 32%
Mar 08In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Nanjing Julong Science & TechnologyLTD has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 9/30/2024 | 2,196 | 75 | 31 | 169 | N/A |
| 6/30/2024 | 2,074 | 81 | 12 | 138 | N/A |
| 3/31/2024 | 1,956 | 83 | -43 | 63 | N/A |
| 12/31/2023 | 1,829 | 73 | -88 | -4 | N/A |
| 9/30/2023 | 1,732 | 80 | -90 | -24 | N/A |
| 6/30/2023 | 1,678 | 68 | -87 | -16 | N/A |
| 3/31/2023 | 1,619 | 53 | -35 | 27 | N/A |
| 1/1/2023 | 1,708 | 55 | -48 | 28 | N/A |
| 9/30/2022 | 1,734 | 30 | -45 | 5 | N/A |
| 6/30/2022 | 1,692 | 27 | -10 | 33 | N/A |
| 3/31/2022 | 1,694 | 31 | -43 | 2 | N/A |
| 1/1/2022 | 1,659 | 32 | -95 | -57 | N/A |
| 9/30/2021 | 1,532 | 42 | -125 | -111 | N/A |
| 6/30/2021 | 1,421 | 40 | -196 | -152 | N/A |
| 3/31/2021 | 1,364 | 71 | -135 | -88 | N/A |
| 12/31/2020 | 1,139 | 61 | -34 | 15 | N/A |
| 9/30/2020 | 1,034 | 63 | -17 | 70 | N/A |
| 6/30/2020 | 968 | 62 | 22 | 85 | N/A |
| 3/31/2020 | 857 | 28 | -15 | 43 | N/A |
| 12/31/2019 | 953 | 29 | -14 | 32 | N/A |
| 9/30/2019 | 942 | 26 | 21 | 32 | N/A |
| 6/30/2019 | 969 | 26 | 19 | 41 | N/A |
| 3/31/2019 | 1,006 | 23 | -15 | 3 | N/A |
| 12/31/2018 | 1,018 | 23 | -43 | -25 | N/A |
| 9/30/2018 | 1,090 | 39 | -77 | -46 | N/A |
| 6/30/2018 | 1,066 | 47 | N/A | -44 | N/A |
| 3/31/2018 | 1,057 | 55 | N/A | -18 | N/A |
| 12/31/2017 | 1,024 | 56 | N/A | 4 | N/A |
| 12/31/2016 | 903 | 79 | N/A | 40 | N/A |
| 12/31/2015 | 820 | 75 | N/A | 54 | N/A |
| 12/31/2014 | 915 | 42 | N/A | 13 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 300644's forecast earnings growth is above the savings rate (2.8%).
Earnings vs Market: Insufficient data to determine if 300644's earnings are forecast to grow faster than the CN market
High Growth Earnings: Insufficient data to determine if 300644's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 300644's revenue is forecast to grow faster than the CN market.
High Growth Revenue: Insufficient data to determine if 300644's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 300644's Return on Equity is forecast to be high in 3 years time